飞救E信
Published by:
IVT Technology
Description
简介：“实时查看移动急救系统，可快速建立急救工作信息，快捷转载上传，图片与语音，语音通话，视频会诊，病痛诊断”救治，实现跨医院、跨科室协同救治患者。
为何要使用飞救E信：
1.工作组：扫描腕带，快速建立一套。
2.多媒体消息：可在线图文、语音、一录音，操作简单，无障碍按键。
3.数据采集：可实时监控数据，查看影像信息、共享病历信息。
4.更多功能：可实时视频实现移动会诊、对患者可进行转诊转归，方便快捷。
为何要使用飞救E信：
1.工作组：扫描腕带，快速建立一套。
2.多媒体消息：可在线图文、语音、一录音，操作简单，无障碍按键。
3.数据采集：可实时监控数据，查看影像信息、共享病历信息。
4.更多功能：可实时视频实现移动会诊、对患者可进行转诊转归，方便快捷。
Screenshots
飞救E信 FAQ
-
Is 飞救E信 free?
Yes, 飞救E信 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 飞救E信 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 飞救E信 cost?
飞救E信 is free.
-
What is 飞救E信 revenue?
To get estimated revenue of 飞救E信 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Brazil yet.
Ratings History
飞救E信 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
飞救E信 Installs
Last 30 days
飞救E信 Revenue
Last 30 days飞救E信 Revenue and Downloads
Gain valuable insights into 飞救E信 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- IVT Technology
- Languages
- Chinese
- Recent release
- 1.2.7 (10 months ago )
- Released on
- Aug 16, 2017 (7 years ago )
- Also available in
- China , Poland , India , Italy , Japan , South Korea , Lebanon , Mexico , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , Ireland , Portugal , Russia , Saudi Arabia , Singapore , Thailand , Türkiye , Taiwan , United States , Vietnam , South Africa , Denmark , Argentina , Austria , Australia , Belgium , Brazil , Canada , Switzerland , Chile , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Ecuador , Egypt , Spain , Finland , France , Greece , Hong Kong SAR China , Hungary , Indonesia
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.